CANCER 2026 , ,
Presentations this author is a contributor to:
Mechanistic deconvolution reveals DHODH as the key target of the KDM4 inhibitor QC6352 (#163)
5:40 PM
Jacinda JH Holtsmark
Welcome Reception & Poster Session 1
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma (#172)
5:40 PM
Emma G Kempe
Welcome Reception & Poster Session 1
A blueprint for mutation-defined hallmark vulnerabilities across human cancers (#146)
5:40 PM
Yuchen Feng
Welcome Reception & Poster Session 1
PRDM9-Mediated H3K4me3 Drives Cholesterol Metabolic Gene Expression and Chemotherapy Tolerance in Glioblastoma (#168)
5:40 PM
George L Joun
Welcome Reception & Poster Session 1
Target Validation in Cancer Drug Discovery: Why It Matters (134218)
9:30 AM
Lenka Munoz
Session 6: Cancer dependencies and novel therapeutic technologies